Weekly Roundup: September 20, 2018


Aparna Krishnan

Episode Description

Back from a summer break! The P4A team discuss the reasons behind NICE’s rejection of Novartis’ CAR-T therapy Kymriah, Denmark and Norway’s joint drug purchasing agreement and US patient groups pushing back against ICER’s influence in drug reimbursement.
Presenter: Max Rex
Contributor: Aparna Krishnan

Latest episodes

Share this podcast